Preventing ovarian hyperstimulation syndrome: cabergoline versus coasting.

Item

http://www.wikidata.org/entity/Q50991217

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Preventing ovarian hyperstimulation syndrome: cabergoline versus coasting.

@en

Preventing ovarian hyperstimulation syndrome: cabergoline versus coasting.

@nl

type

Item

label

Preventing ovarian hyperstimulation syndrome: cabergoline versus coasting.

@en

Preventing ovarian hyperstimulation syndrome: cabergoline versus coasting.

@nl

prefLabel

Preventing ovarian hyperstimulation syndrome: cabergoline versus coasting.

@en

Preventing ovarian hyperstimulation syndrome: cabergoline versus coasting.

@nl

P1476

Preventing ovarian hyperstimulation syndrome: cabergoline versus coasting

@en

P2093

Gurkan Bozdag

http://www.w3.org/2001/XMLSchema#string

Lale Karakocsokmensuer

http://www.w3.org/2001/XMLSchema#string

P2860

Can dopamine agonists reduce the incidence and severity of OHSS in IVF/ICSI treatment cycles? A systematic review and meta-analysis

Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified 'coasting' strategy based on ultrasound for identification of high-risk patients.

Intravenous albumin for preventing severe ovarian hyperstimulation syndrome: a Cochrane review.

New concepts in the understanding of the ovarian hyperstimulation syndrome.

Coasting for the prevention of ovarian hyperstimulation syndrome: much ado about nothing?

GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy?

Symposium: Update on prediction and management of OHSS. Prevention of OHSS.

The use of laparoscopic ovarian electrocautery in preventing cancellation of in-vitro fertilization treatment cycles due to risk of ovarian hyperstimulation syndrome in women with polycystic ovaries.

The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.

Failure of cabergoline to prevent severe ovarian hyperstimulation syndrome in patients with extremely high estradiol levels.

P2888

s00404-013-2875-z

P304

1159-1163

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00404-013-2875-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

288

http://www.w3.org/2001/XMLSchema#string

P50

Ibrahim Esinler

P577

2013-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23677417

http://www.w3.org/2001/XMLSchema#string